Author Archives for Stemedica International

Clinical Trials for Alzheimer’s Disease (CTAD) Selects Stemedica International to Present at Annual International Conference

November 21, 2016 9:51 am Published by Comments Off on Clinical Trials for Alzheimer’s Disease (CTAD) Selects Stemedica International to Present at Annual International Conference

https://awesomeamsterdam.com/outline-example-for-a-research-paper/ go donde. comprar viagra en kansas city essaypapershelp com how much is viagra at walmart without insurance help homework drama viagra blue pill for sale research paper tips models for writers short essays for composition what happens to girls on viagra https://jesuswired.com/writing/learning-different-languages-essay/12/ http://www.conn29th.org/university/how-to-write-a-why-us-college-essay.htm order prednisone overnight delivery cat essay writer printmaking paper http://skatehousemedia.com/cv/how-do-i-check-what-generation-my-ipad-is/12/ viagra weekender viagra mechanism of action video http://floatinglotus.com/prescription/synthroid-effects-on-blood-sugar/50/ https://skincitybodypainting.com/21107-thesis-statement-in-contrast-essay/ nyu college essay source link buy cialis online cheap https://stageone.org/argument-essay-prompts/ http://www.chesszone.org/lib/llm-thesis-abstract-9822.html by levitra price source buy paper hand towels in bulk help writing papers for college evaluation paper sample https://skincitybodypainting.com/9354-thesis-proposal-presentation-example/ aortic abdominal aneurysm and viagra San Diego, California and Lausanne, Switzerland — November 21, 2016 Stemedica International, SA, a leader in the development of innovative stem...
Read Entire Article


University of California Irvine (UCI) Doses First Patient in Phase IIa Clinical Trial Using Stemedica’s Stem Cells for Alzheimer’s disease

November 1, 2016 5:55 am Published by Comments Off on University of California Irvine (UCI) Doses First Patient in Phase IIa Clinical Trial Using Stemedica’s Stem Cells for Alzheimer’s disease

IRVINE, CA — November 1, 2016 — Stemedica International, SA, a Stemedica Cell Technologies Inc. subsidiary that uses its proprietary...
Read Entire Article


University of California Irvine (UCI) Doses First Patient in Phase IIa Clinical Trial Using Stemedica’s Stem Cells for Alzheimer’s disease

October 26, 2016 9:53 am Published by Comments Off on University of California Irvine (UCI) Doses First Patient in Phase IIa Clinical Trial Using Stemedica’s Stem Cells for Alzheimer’s disease

Lausanne, Switzerland — October 26, 2016 Stemedica International, SA, a leader in the development of innovative stem cell-based treatments for Alzheimer’s...
Read Entire Article


Stemedica International Receives Approval from Emory University to Initiate Alzheimer’s Disease Study with Adult Allogeneic Stem Cells

February 24, 2016 5:54 am Published by Comments Off on Stemedica International Receives Approval from Emory University to Initiate Alzheimer’s Disease Study with Adult Allogeneic Stem Cells

Lausanne, Switzerland — February 24, 2016 — Stemedica International, SA, a leader in the development of innovative stem cell-based treatments...
Read Entire Article